Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2016

Open Access 01-12-2016 | Research article

Gender-modulated risk of coronary heart disease, diabetes and coronary mortality among Turks for three major risk factors, and residual adiposity risk

Authors: Günay Can, Altan Onat, Eray Yurtseven, Yusuf Karadeniz, Tuğba Akbaş-Şimşek, Ayşem Kaya, Hüsniye Yüksel

Published in: BMC Endocrine Disorders | Issue 1/2016

Login to get access

Abstract

Background

We determined the proportion of the effects of body mass index (BMI) or its categories on cardiometabolic outcomes mediated through systolic blood pressure (SBP), total cholesterol and fasting glucose.

Methods

Cox regression analyses were performed for incident outcomes among Turkish Adult Risk Factor study participants in whom the three mediators had been determined (n = 2158, age 48.5 ± 11 years). Over a mean 10.2-years’ follow-up, new coronary heart disease (CHD) developed in 406, diabetes in 284 individuals, and 149 CHD deaths occurred.

Results

Hazard ratios (HR) of BMI for incident diabetes were no more than marginally attenuated by the 3 mediators including glucose, irrespective of gender. Compared to “normal-weight”, sex- and age-adjusted RRs for incident CHD of overweight and obesity were 1.40 and 2.24 (95 % CI 1.68; 2.99), respectively, in gender combined. Only three-tenths of the excess risk was retained by BMI in men, six-tenths in women. No mediation of glycemia was discerned in males, in contrast to greatest mediation in females. HR of age-adjusted continuous BMI was a significant but modest contributor to CHD mortality in each gender. While the BMI risk of CHD death was abolished by mediation of SBP in men, HR strengthened to over two-fold in women through mediation of fasting glucose.

Conclusions

Mediation of adiposity by 3 traditional factors exhibited among Turkish adults strong gender dependence regarding its magnitude for CHD risk and the mediation by individual risk factors. Retention of the large part of risk for diabetes in each sex and for CHD in women likely reflects underlying autoimmune activation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377:1085–95.CrossRefPubMed Wormser D, Kaptoge S, Di Angelantonio E, Wood AM, Pennells L, Thompson A, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377:1085–95.CrossRefPubMed
2.
go back to reference Song X, Jousilahti P, Stehouwer CDA, Söderberg S, Onat A, Laatikainen T, Yudkin JS, Dankner R, Morris R, Tuomilehto J, Qiao Q. Cardiovascular and all-cause mortality in relation to various anthropometric measures of obesity in Europeans. Nutr Metab Cardiovasc Dis. 2015;25(3):295–304.CrossRefPubMed Song X, Jousilahti P, Stehouwer CDA, Söderberg S, Onat A, Laatikainen T, Yudkin JS, Dankner R, Morris R, Tuomilehto J, Qiao Q. Cardiovascular and all-cause mortality in relation to various anthropometric measures of obesity in Europeans. Nutr Metab Cardiovasc Dis. 2015;25(3):295–304.CrossRefPubMed
3.
go back to reference Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372–9.CrossRefPubMed Jousilahti P, Tuomilehto J, Vartiainen E, Pekkanen J, Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372–9.CrossRefPubMed
4.
go back to reference Batty GD, Shipley MJ, Jarrett RJ, Breeze E, Marmot MG, Davey SG. Obesity and overweight in relation to disease-specific mortality in men with and without existing coronary heart disease in London: the original whitehall study. Heart. 2006;92:886–92.CrossRefPubMed Batty GD, Shipley MJ, Jarrett RJ, Breeze E, Marmot MG, Davey SG. Obesity and overweight in relation to disease-specific mortality in men with and without existing coronary heart disease in London: the original whitehall study. Heart. 2006;92:886–92.CrossRefPubMed
5.
go back to reference Ni Mhurchu C, Rodgers A, Pan WH, Gu DF, Woodward M, Collaboration APCS. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol. 2004;33:751–8.CrossRefPubMed Ni Mhurchu C, Rodgers A, Pan WH, Gu DF, Woodward M, Collaboration APCS. Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol. 2004;33:751–8.CrossRefPubMed
6.
go back to reference Bogers RP, Bemelmans WJ, Hoogenveen RT, The BMI-CHD Collaboration Investigators. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167:1720–8.CrossRefPubMed Bogers RP, Bemelmans WJ, Hoogenveen RT, The BMI-CHD Collaboration Investigators. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med. 2007;167:1720–8.CrossRefPubMed
7.
go back to reference Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaborating Group (BMI-mediated Effects). Metabolic mediators of the effects of body-mass-index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383:970–83.CrossRefPubMed Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, Danaei G. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaborating Group (BMI-mediated Effects). Metabolic mediators of the effects of body-mass-index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383:970–83.CrossRefPubMed
8.
go back to reference Onat A, Hergenç G. Low-grade inflammation and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. Metabolism. 2011;60:499–512.CrossRefPubMed Onat A, Hergenç G. Low-grade inflammation and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. Metabolism. 2011;60:499–512.CrossRefPubMed
9.
go back to reference Onat A, Avcı GŞ, Şenocak M, Örnek E, Gözükara Y. Plasma lipids and their interrelation in Turkish adults. J EpidemCommun Health. 1992;46:470–6. Onat A, Avcı GŞ, Şenocak M, Örnek E, Gözükara Y. Plasma lipids and their interrelation in Turkish adults. J EpidemCommun Health. 1992;46:470–6.
10.
go back to reference Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486–97. Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486–97.
11.
go back to reference Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.CrossRefPubMed Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–8.CrossRefPubMed
12.
go back to reference Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis. 2007;191:182–90.CrossRefPubMed Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis. 2007;191:182–90.CrossRefPubMed
13.
go back to reference Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al. Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus: the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:3160–7. PMID: 14578255.CrossRefPubMed Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al. Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus: the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:3160–7. PMID: 14578255.CrossRefPubMed
14.
go back to reference Rose G, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods, 2nd ed. Geneva: WHO; 1982. p. 124–7. Rose G, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods, 2nd ed. Geneva: WHO; 1982. p. 124–7.
15.
go back to reference Lin DY, Fleming TR, Gruttola V. Estimating the proportion of treatment effect by a surrogate marker. Stat Med. 1997;16:1515–27.CrossRefPubMed Lin DY, Fleming TR, Gruttola V. Estimating the proportion of treatment effect by a surrogate marker. Stat Med. 1997;16:1515–27.CrossRefPubMed
16.
go back to reference Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91.CrossRefPubMed Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91.CrossRefPubMed
17.
go back to reference Fuentes E, Fuentes F, Vilahur G, Badimon L, Palomo I. Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm. 2013; 136584. doi: 10.1155/2013/136584 Fuentes E, Fuentes F, Vilahur G, Badimon L, Palomo I. Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm. 2013; 136584. doi: 10.​1155/​2013/​136584
18.
go back to reference Danaei G, Finucane MM, Lu Y, For the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood glucose), et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40.CrossRefPubMed Danaei G, Finucane MM, Lu Y, For the Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood glucose), et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40.CrossRefPubMed
19.
go back to reference Onat A, Can G. Enhanced pro-inflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases. Curr Pharm Design. 2014;20:575–84.CrossRef Onat A, Can G. Enhanced pro-inflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases. Curr Pharm Design. 2014;20:575–84.CrossRef
20.
go back to reference Singh GM, Danaei G, Farzadfar F, The Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group.Asia-Pacific Cohort Studies Collaboration (APCSC); The Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE); The Emerging Risk Factor Collaboration (ERFC); The Prospective Studies Collaboration (PSC). The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8:e65174.CrossRefPubMedPubMedCentral Singh GM, Danaei G, Farzadfar F, The Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group.Asia-Pacific Cohort Studies Collaboration (APCSC); The Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE); The Emerging Risk Factor Collaboration (ERFC); The Prospective Studies Collaboration (PSC). The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One. 2013;8:e65174.CrossRefPubMedPubMedCentral
21.
go back to reference Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation. 2006;113:898–918.CrossRefPubMed Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation. 2006;113:898–918.CrossRefPubMed
22.
go back to reference Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875–80.CrossRefPubMed Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875–80.CrossRefPubMed
23.
go back to reference Onat A, Aydın M, Can G, Çakmak HA, Köroğlu B, Kaya A, Ademoğlu E. Impaired fasting glucose: pro-diabetic, “atheroprotective” and modified by metabolic syndrome. World J Diabetes. 2013;4:210–8.PubMedPubMedCentral Onat A, Aydın M, Can G, Çakmak HA, Köroğlu B, Kaya A, Ademoğlu E. Impaired fasting glucose: pro-diabetic, “atheroprotective” and modified by metabolic syndrome. World J Diabetes. 2013;4:210–8.PubMedPubMedCentral
24.
go back to reference Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–37.CrossRefPubMed Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298:2028–37.CrossRefPubMed
25.
go back to reference Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. J Am Med Assn. 2013;309:71–82.CrossRef Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. J Am Med Assn. 2013;309:71–82.CrossRef
26.
go back to reference Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.CrossRefPubMedCentral Prospective Studies Collaboration, Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–96.CrossRefPubMedCentral
27.
go back to reference Çoban N, Onat A, Güçlu-Geyik F, Can G, Erginel-Unaltuna N. Sex- and obesity-specific association of CYP19A1 gene variant with apolipoprotein B and hypertension. Arch Med Res. 2015;46:564–71.CrossRefPubMed Çoban N, Onat A, Güçlu-Geyik F, Can G, Erginel-Unaltuna N. Sex- and obesity-specific association of CYP19A1 gene variant with apolipoprotein B and hypertension. Arch Med Res. 2015;46:564–71.CrossRefPubMed
28.
go back to reference Ahmad T, Chasman DI, Mora S, Paré G, Cook NR, Buring JE, Ridker PM, Lee J-M. The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am Heart J. 2010;160:1163–9.CrossRefPubMedPubMedCentral Ahmad T, Chasman DI, Mora S, Paré G, Cook NR, Buring JE, Ridker PM, Lee J-M. The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am Heart J. 2010;160:1163–9.CrossRefPubMedPubMedCentral
Metadata
Title
Gender-modulated risk of coronary heart disease, diabetes and coronary mortality among Turks for three major risk factors, and residual adiposity risk
Authors
Günay Can
Altan Onat
Eray Yurtseven
Yusuf Karadeniz
Tuğba Akbaş-Şimşek
Ayşem Kaya
Hüsniye Yüksel
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2016
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-016-0134-6

Other articles of this Issue 1/2016

BMC Endocrine Disorders 1/2016 Go to the issue